Back

Transseptal endocardial left ventricular lead implantation is an effective and feasible method and exerts long lastig beneficial haemodynamical effects after failed CRT implantation

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Implantable devices: what's new? Cardiac Resynchronisation Therapy (CRT) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Laszlo Alajos Geller

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
Risk of atrial fibrillation after pm implantation: a nationwide danish registry-based follow-up study
Doctor B. Tayal (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Impact of anti-coagulation therapy on in-hospital outcomes of CRT patient treated with transvenous lead extraction
Doctor F. Regoli (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
The acute extravascular defibrillation, pacing and electrogram (ASD2) study results
Professor B. Merkely (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Use of 3D printed models as a tool to obtain feedback on delivery tool design for a novel extravascular ICD implant procedure
Ms B. Portway (Mounds View, US)
Abstract
Presentation thumbnail
Lead material retention and clinical outcomes in patients undergoing transvenous lead extraction
Doctor A. Hussein (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Implantable devices: what's new?

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Presentation
Device therapy: how to identify responders?
thumbnail
Congress Presentation
Cardiac resynchronisation therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources